Assoc Prof Dr. Teresa Vanessa Fiorentino | Medicina Interna | Best Researcher Award
Professor Associate at University of Magna Graecia of Catanzaro, Italy.
Teresa Vanessa Fiorentino is an accomplished Associate Professor in Internal Medicine at the University of Magna Græcia, Catanzaro, with an impressive career in academic research, focusing on diabetes and metabolic disorders. With international research experience and numerous publications in high-impact journals, Dr. Fiorentino has established herself as a leading figure in her field. She actively contributes to the academic and medical communities through her editorial roles, teaching, and participation in scientific societies.
Profile:
Education
Dr. Fiorentino earned her degree in Medicine and Surgery with honors (110/110 cum laude) in 2008 from the University of Magna Græcia in Catanzaro, Italy. She pursued specialization in Internal Medicine at the same institution, graduating with honors in 2014. During her education, she completed a prestigious post-doctoral fellowship at the University of Texas Health Science Center at San Antonio, gaining invaluable experience in diabetes research. In 2018, she also earned a PhD focusing on biomarkers for chronic and complex diseases.
Professional Experience
Dr. Fiorentino has held various academic and research positions throughout her career. From 2014 to 2018, she served as a PhD candidate and research fellow in Internal Medicine. In 2018, she became a fixed-term researcher and has been serving as an Associate Professor at the University of Magna Græcia since December 2021. She also holds clinical responsibilities at the University Hospital “Renato Dulbecco” in Catanzaro, specializing in Internal Medicine. Additionally, she has been a faculty member in multiple PhD programs and specializations.
Research Interest
Dr. Fiorentino’s research interests are primarily centered around metabolic diseases, particularly type 2 diabetes, insulin resistance, and glucose metabolism. She is also interested in investigating biomarkers for chronic and complex diseases and exploring how molecular and physiological factors contribute to these conditions. Her work emphasizes translational research aimed at improving the prediction, prevention, and treatment of chronic diseases.
Research Skills
Dr. Bushra Bashir’s research skills encompass a broad range of techniques essential for advanced organic chemistry. She is proficient in synthesis, chromatography, recrystallization, and extraction, which are crucial for developing and purifying chemical compounds. Her expertise extends to spectroscopic characterization and crystallography, providing detailed analysis of molecular structures. Additionally, Dr. Bashir is skilled in using research software such as Chemdraw, Mestrenova, IBM SPSS, Origin, and Endnote, which support data analysis and research documentation.
Award and Recognition
Conclusion
Publication Top Notes
- Compromised cardiac autonomic function in non-diabetic subjects with 1 h post-load hyperglycemia: a cross-sectional study
Authors: Monea, G., Jiritano, R., Salerno, L., Fiorentino, T.V., Andreozzi, F.
Year: 2024
📄 Cardiovascular Diabetology, 23(1), 295
Citations: 0 - Association between augmented levels of the gut pro-hormone Proneurotensin and subclinical vascular damage
Authors: De Vito, F., Fiorentino, T.V., Facciolo, A., Sesti, G., Andreozzi, F.
Year: 2024
📄 Scientific Reports, 14(1), 15086
Citations: 0 - Sex-specific differences in myocardial glucose metabolic rate in non-diabetic, pre-diabetic, and type 2 diabetic subjects
Authors: Succurro, E., Vizza, P., Cicone, F., Cascini, G.L., Sesti, G.
Year: 2024
📄 Cardiovascular Diabetology, 23(1), 144
Citations: 0 - Mean platelet volume (MPV) as a new marker of diabetic macrovascular complications in patients with different glucose homeostasis: Platelets in cardiovascular risk
Authors: Cassano, V., Armentaro, G., Iembo, D., Pujia, A., Sciacqua, A.
Year: 2024
📄 Cardiovascular Diabetology, 23(1), 89
Citations: 3 - GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes
Authors: Ciardullo, S., Morieri, M.L., Daniele, G., Solini, A., Avogaro, A.
Year: 2024
📄 Acta Diabetologica, 61(8), pp. 941–950
Citations: 0 - Frequency of prediabetes in individuals with increased adiposity and metabolically healthy or unhealthy phenotypes
Authors: Cefalo, C.M.A., Riccio, A., Succurro, E., Andreozzi, F., Sesti, G.
Year: 2024
📄 Diabetes, Obesity and Metabolism, 26(8), pp. 3191–3199
Citations: 1 - Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule
Authors: Ben Nasr, M., Usuelli, V., Dellepiane, S., Folli, F., Fiorina, P.
Year: 2024
📄 Cell Metabolism, 36(6), pp. 1302–1319.e12
Citations: 3 - Myocardial mechano-energetic efficiency is not impaired in patients with metabolically healthy overweight and obesity
Authors: Cefalo, C.M.A., Riccio, A., Fiorentino, T.V., Andreozzi, F., Sesti, G.
Year: 2024
📄 Obesity, 32(5), pp. 888–899
Citations: 0 - Asymmetric dimethylarginine (ADMA) is associated with reduced myocardial mechano-energetic efficiency in hypertensive subjects
Authors: Cefalo, C.M.A., Riccio, A., Fiorentino, T.V., Perticone, F., Sesti, G.
Year: 2024
📄 Nutrition, Metabolism and Cardiovascular Diseases, 34(5), pp. 1175–1178
Citations: 0 - Whole blood viscosity is associated with reduced myocardial mechano-energetic efficiency in non-diabetic individuals
Authors: Riccio, A., Cefalo, C.M.A., Mazzanti, C., Andreozzi, F., Sesti, G.
Year: 2024
📄 European Journal of Clinical Investigation, 54(3), e14127
Citations: 1